Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Assets (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Assets for 13 consecutive years, with $11162.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 49.96% year-over-year to $11162.0, compared with a TTM value of $11162.0 through Nov 2025, down 49.96%, and an annual FY2025 reading of $18437.0, down 41.25% over the prior year.
  • Assets was $11162.0 for Q4 2025 at CNBX Pharmaceuticals, down from $18437.0 in the prior quarter.
  • Across five years, Assets topped out at $5.0 million in Q1 2021 and bottomed at $11162.0 in Q4 2025.
  • Average Assets over 5 years is $994944.4, with a median of $480545.5 recorded in 2023.
  • The sharpest move saw Assets soared 39.08% in 2021, then tumbled 94.24% in 2024.
  • Year by year, Assets stood at $2.1 million in 2021, then plummeted by 71.25% to $609509.0 in 2022, then tumbled by 36.44% to $387402.0 in 2023, then crashed by 94.24% to $22308.0 in 2024, then tumbled by 49.96% to $11162.0 in 2025.
  • Business Quant data shows Assets for CNBX at $11162.0 in Q4 2025, $18437.0 in Q3 2025, and $18615.0 in Q2 2025.